Given the fact that, in mice with prostate cancer, b2-AR activation by stress induces MDSCs accumulation on tumor site, is reasonable to hypothesize that the immunosuppressive functions of such metabolic pathways in prostate cancer are correlated with MDSCs. The gene discussed is ADRB2; the disease is Familial prostate cancer.